Publication | Open Access

De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03): 5-year follow-up results of a Dutch, prospective, registry study

Radiation MedicineRegistry StudyCancer TherapeuticsRadiation TherapyCt1–2n1 Breast CancerMedicineBreast CancerPrimary ChemotherapyClinical Radiation OncologyOncologyRadiation OncologyCancer ResearchRadiologyHealth Sciences